IONIS PHARMACEUTICALS INC - Common Stock (IONS)

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / Common Stock
Shares outstanding
161,813,505
Total 13F shares
120,736,011
Share change
+1,619,625
Total reported value
$3,673,847,924
Put/Call ratio
192%
Price per share
$30.43
Number of holders
313
Value change
+$47,440,866
Number of buys
141
Number of sells
143

Institutional Holders of IONIS PHARMACEUTICALS INC - Common Stock (IONS) as of Q4 2021

As of 31 Dec 2021 IONIS PHARMACEUTICALS INC - Common Stock (IONS) had 313 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions held a total of 120,736,011 shares of stock of the company.
Largest 10 holders included FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, Bellevue Group AG, BlackRock Inc., ARK Investment Management LLC, Clearbridge Investments, LLC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, and FIRST TRUST ADVISORS LP.
This table shows 316 institutional shareholders of the security as of 31 Dec 2021.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.